Structural Biology in Drug Discovery
Structural biology plays a pivotal role in rational drug design and therapeutic development. High-resolution structural data enable identification of active sites, binding pockets, and molecular interactions critical for target modulation. Structure-based drug discovery integrates crystallography, cryo-EM, NMR, and computational docking to optimize lead compounds. Fragment-based screening approaches facilitate identification of promising drug candidates. Structural insights support the development of selective inhibitors with improved efficacy and reduced toxicity. Understanding resistance mechanisms at the molecular level informs next-generation therapeutic strategies. Integration of structural data with pharmacological studies accelerates translational research. Advances in precision medicine increasingly rely on detailed structural knowledge to design targeted therapies for complex diseases.